Prevention of subcutaneous seroma formation in open ventral hernia repair using a new low-thrombin fibrin sealant

World J Surg. 2014 Nov;38(11):2797-803. doi: 10.1007/s00268-014-2691-z.

Abstract

Background: Seroma formation is a frequent postoperative complication following open ventral hernia repair (OVHR), especially in cases requiring wide subcutaneous dissection (WSD). The aim of this study was to evaluate the effectiveness of a new low-thrombin fibrin sealant for seroma prevention.

Methods: A total of 60 consecutive patients with median incisional hernias who required OVHR with WSD of at least 100 cm(2) were included in the prospective non-randomized study. The fibrin glue group (FG) comprised 30 patients who had undergone OVHR with sublay mesh placement as well as subcutaneous application of low-thrombin fibrin sealant. This cohort of patients was compared with a control group (CG) of 30 consecutive patients who had previously undergone OVHR without prevention of seroma formation with regard to outcome measures such as seroma formations and wound complications.

Results: Though the median extent of subcutaneous dead space was larger in the FG than in the CG (229 vs.174 cm(2); p = 0.012), seroma formation occurred in three of the FG versus 16 of the CG patients (p = 0.003). Postoperative wound complications occurred in two of the FG versus nine of the CG patients (p = 0.002). Four patients in the CG and none in the FG required re-operation within 30 days (p < 0.001).

Conclusion: The use of a new low-thrombin fibrin glue demonstrated a protective effect against formation of seromas and decreased the rate of wound complications in OVHR, with consecutive shorter length of hospital stay (5.8 vs. 10.4 days; p = 0.04).

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Female
  • Fibrin Tissue Adhesive / chemistry*
  • Fibrin Tissue Adhesive / therapeutic use
  • Hernia, Ventral / surgery*
  • Herniorrhaphy / methods*
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Postoperative Complications / prevention & control*
  • Prospective Studies
  • Seroma / etiology
  • Seroma / prevention & control*
  • Thrombin
  • Tissue Adhesives / chemistry*
  • Tissue Adhesives / therapeutic use

Substances

  • Fibrin Tissue Adhesive
  • Tissue Adhesives
  • Thrombin